 in-vitro assess hypersensit syndrom sorbinil sorbinil hydantoin aldos reductas inhibitor promis therapi patient diabet complic neuropathi retinopathi mani patient sorbinil advers reaction fever skin rash myalgia previou studi phenytoin suscept reaction inherit detoxif defect current studi sorbinil intermedi cell patient histori reaction appropri in-vitro investig suscept microsome-gener metabolit sorbinil microm toxic normal peripher blood lymphocyt dead cell mean SE toxic presenc epoxid hydrolas inhibitor dead cell inhibitor cytochrom contrast cell healthi control diabet sorbinil dead cell cell patient reaction toxic metabolit sorbinil phenytoin dead cell cell patient reaction sensit metabolit dead cell sorbinil toxic intermedi certain patient risk hypersensit reaction develop import new drug uncommon sever reaction increas understand step develop advers reaction test develop safer compound